Patent · US Active

Parenteral norovirus vaccine formulations

US9867876B2 · kind B2 · utility

8Cited by
23References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 10, 2015
Grant dateJan 16, 2018
Priority date
Expiry dateJul 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/16034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.